EPHX1 was reported to be linked to bone disease, as revealed by testing genomic DNA from myeloma patients using a custom‐built DNA single nucleotide polymorphism (SNP) chip.28 Soluble EPHX is a phase‐I xenobiotic metabolising enzyme. The gene discussed is EPHX1; the disease is plasma cell myeloma.